Skip to main content


Page 7 of 7

  1. This report describes the clinical courses of two acute myeloid leukemia patients. Both had MLL translocations, the first a t(10;11)(p11.2;q23) with MLL-AF10 and the second a t(11;19)(q23;p13.1) with MLL-ELL fusi...

    Authors: Thomas Burmeister, Mara Molkentin, Claus Meyer, Nils Lachmann, Stefan Schwartz, Birte Friedrichs, Jörg Beyer, Igor Wolfgang Blau, Gunnar Lohm, Carola Tietze-Bürger, Rolf Marschalek and Lutz Uharek

    Citation: Experimental Hematology & Oncology 2012 1:6

    Content type: Case report

    Published on:

  2. A growing body of evidence indicates that digitoxin cardiac glycoside is a promising anticancer agent when used at therapeutic concentrations. Digitoxin has a prolonged half-life and a well-established clinica...

    Authors: Hosam A Elbaz, Todd A Stueckle, William Tse, Yon Rojanasakul and Cerasela Zoica Dinu

    Citation: Experimental Hematology & Oncology 2012 1:4

    Content type: Review

    Published on:

  3. Oxidative stress and redox-regulating enzymes may have roles both in lymphomagenesis and resistance to lymphoma therapy. Previous studies from the pre-rituximab era suggest that antioxidant enzyme expression i...

    Authors: Pekka Peroja, Anna Kaisa Pasanen, Kirsi-Maria Haapasaari, Esa Jantunen, Ylermi Soini, Taina Turpeenniemi-Hujanen, Risto Bloigu, Laura Lilja, Outi Kuittinen and Peeter Karihtala

    Citation: Experimental Hematology & Oncology 2012 1:2

    Content type: Research

    Published on:

Annual Journal Metrics